Add Yahoo as a preferred source to see more of our stories on Google. Many studies show there is a significant benefit from even a small amount of physical activity. - Emilija Manevska/Moment RF/Getty ...

Randomized data support structured post-adjuvant exercise as a disease-modifying survivorship strategy, improving disease-free survival and overall survival compared with education-only control.

Exercising regularly in the three years after treatment for a common cancer could significantly improve survival rates, an international study has revealed. In the research, a total of 889 colon ...

Aerobic activity, strength training, stretching, and mindful movement practices can help people with breast cancer improve ...

New research suggests that exercise may help people with cancer stay mentally sharp and better able to handle daily tasks, work, and social activities through chemotherapy treatment delivered on an ...

EXCAP delivered individualized daily step goals, resistance-band training, and activity diaries entirely at home, enabling scalable implementation within routine chemotherapy supportive-care pathways.

A recent randomized controlled trial reveals the potential of a program designed to connect patients who have breast cancer to needed exercise and rehabilitation services starting at diagnosis and ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

The answer depends on your individual risk for bone fracture and the type of exercise. For most men with early prostate cancer, its safe to engage in light or moderate exercise. Physical activity is ...

Cutout of pink plastic dumbbell grabbed by hands of cheerful Asian woman patient of breast cancer as physical therapy and exercise tool for strong health and moral refreshing against illness A new ...

Colon cancer patients saw improved survival rates after a 3-year exercise program, according to a first-of-its-kind international experiment. The research, presented at the American Society of ...

EP4 Antagonist ONO-4578 Plus Nivolumab and Chemotherapy in Human Epidermal Growth Factor Receptor 2–Negative Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer This ...